UK behavioural investigations

UK behavioural investigations guidance:

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 6 December 2013; it is no longer maintained. Case facts OutlineOFT Chapter I...

Practice Note

CASE HUB See further, timeline, commentary and related cases. Case facts OutlineCMA Article 102 TFEU/Chapter II investigation into Actavis UK in relation to an alleged...

Practice Note

CASE HUB See further, timeline ,commentary and related cases. Case facts OutlineCMA Article 101 TFEU/Chapter I investigation into AMCo (now Advanz Pharma Services (UK)...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 21 February 2019; it is no longer maintained. See further, timeline and...

Practice Note

CASE HUB See further,timeline , commentary and related cases. Case facts OutlineCMA Article 101 TFEU/Chapter I CA98 investigation into a revenue-sharing agreement, known...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 10 May 2016; it is no longer maintained. See further, timeline, commentary...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 31 October 2013; it is no longer maintained. Case facts OutlineOFT Article...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 20 March 2014; it is no longer maintained. See further, timeline. Case facts...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 4 June 2019; it is no longer maintained. See further, timeline, commentary...

Practice Note

CASE HUB ARCHIVED—this archived case hub reflects the position at the date of the decision of 1 August 2019; it is no longer maintained. See further: timeline, commentary...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 14 December 2017; it is no longer maintained. See further, timeline and...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 24 May 2016; it is no longer maintained. See further, timeline, commentary...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 16 December 2016; it is no longer maintained. See further, timeline,...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 25 October 2018; it is no longer maintained. See further, timeline and...

Practice Note

CASE HUB ARCHIVED—this archived case hub reflects the position at the date of the announcement of director disqualification undertakings of 31 July 2019; it is no longer...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 30 May 2019; it is no longer maintained. See further, timeline and...

Practice Note

CASE HUB See further, timeline, commentary and related cases. Case facts OutlineCMA Article 101 TFEU/Chapter I CA98 investigation alleging that Roland (U.K) Limited...

Practice Note

CASE HUB See further, timeline, commentary andrelated cases Case facts OutlineCMA Article 101 TFEU/Chapter I and Article 102 TFEU/Chapter II investigation into Aspen’s...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the acceptance of commitments on 26 October 2017; it is no longer maintained. See further,...

Practice Note

CASE HUB (Appeals lodged at the Competition Appeal Tribunal–see GlaxoSmithKline and other v CMA (paroxetine)) ARCHIVED–this archived case hub reflects the position at the...

Practice Note

CASE HUB See further: timeline, commentary and related cases. Case facts Outline CMA Article 101 TFEU/Chapter I CA98 investigation alleging that Fender...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 22 January 2020; it is no longer maintained. See further: timeline,...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 16 September 2015 to close the investigation; it is no longer maintained....

Practice Note

CASE HUB See further, timeline, commentary and related cases. Case facts OutlineCMA Article 101 TFEU/Chapter I and Article 102 TFEU/Chapter II investigation into alleged...

Practice Note

CASE HUB See further, timeline, commentary and related cases. Case facts OutlineCMA Article 101 TFEU/Chapter I investigation into Actavis UK and Concordia in relation to...

Practice Note

CASE HUB See further: timeline, commentary and related cases. Case facts OutlineCMA Article 101 TFEU/Chapter I and Article 102 TFEU/Chapter II investigation into Auden...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 3 May 2017; it is no longer maintained. See further, timeline, commentary...

Practice Note

CASE HUB See further, timeline, commentary and related cases. Case facts OutlineCMA Article 102 TFEU/Chapter II investigation into Advanz Pharma (formerly Concordia) in...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 27 March 2013; it is no longer maintained. See further, timeline and related...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 27 March 2014; it is no longer maintained. See further, timeline, commentary...

Practice Note
Trending Topics
In-House COVID-19